AbbVie Inc. (NYSE: ABBV), a United States-based pharmaceutical company, announced on Friday its quarterly cash dividend.
The company has declared cash dividend of USD1.55 per share.
The cash dividend will be paid to stockholders of record at 15 July 2024 on 15 August 2024.
Amgen announces Q3 2024 dividend
Perrigo announces quarterly dividend
Valneva receives CEPI funding to boost access to world's first chikungunya vaccine
Emmaus Life Sciences reports 2023 financial results
Quest Diagnostics to acquire LifeLabs from OMERS for USD1.35bn
Eli Lilly announces Q3 2024 dividend
Valneva's chikungunya vaccine IXCHIQ approved by Health Canada